Steven Kanner serves as Executive at Caribou Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Steven Kanner has executed 12 insider transactions totaling $706.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 20, 2024 involved receiving (via award) 33,000 shares valued at $0.
Steven Kanner currently holds 387,037 shares of Caribou Biosciences, Inc. (CRBU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Kanner has been a net seller of CRBU stock. They have purchased $220.8K and sold $485.2K worth of shares.
Steven Kanner's most recent insider trade was on Feb 20, 2024, when they sold 33,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.69 |
| Discretionary |
| Dec 2, 2022 | CRBU | $57.6K | Option Exercise | 21,401 | $2.69 | Discretionary |
| Aug 25, 2022 | CRBU | $116.3K | Option Exercise | 43,248 | $2.69 | Discretionary |
| Aug 25, 2022 | CRBU | $485.2K | Sale | 43,248 | $11.22 | Discretionary |
| May 13, 2022 | CRBU | $123.6K | Option Exercise | 68,306 | $1.81 | Discretionary |
| May 13, 2022 | CRBU | $16.4K | Option Exercise | 6,114 | $2.69 | Discretionary |
| Mar 4, 2022 | CRBU | $6.4K | Option Exercise | 1,549 | $4.11 | Discretionary |
| Mar 4, 2022 | CRBU | $24.7K | Option Exercise | 9,171 | $2.69 | Discretionary |
| Oct 12, 2021 | CRBU | $1.3K | Purchase | 698 | $1.81 | Discretionary |
| Oct 12, 2021 | CRBU | $39.3K | Purchase | 14,614 | $2.69 | Discretionary |
| Oct 12, 2021 | CRBU | $180.2K | Purchase | 99,548 | $1.81 | Discretionary |